Biotech company PHIOGEN announces the appointment of Chief Operations Officer

PHIOGEN, a pioneering startup developing next-generation bacteriophage-based therapeutics, has appointed Dr. Mayukh Das as Chief Operations Officer (COO). Dr. Das joins PHIOGEN from Johnson & Johnson Innovative Medicine where he served as Associate Scientific Director of Phage Microbiology and brings with him more than 19 years’ experience managing medical research and pharmaceutical product development. Dr.…


Major breakthrough in bacteriophage research launches start-up to solve infection crisis

Ambitious new biotech venture PHIOGEN has developed a world-first technology platform that mobilizes the natural power of bacteriophages to tackle critical and life-threatening infections, marking a significant medical breakthrough for countering the global threat of antimicrobial resistance.  The company will make its debut at the 6th World Congress on Targeting Phage Therapy in Paris, June…